US2005101619A1PendingUtilityA1
Anti-picornaviral compounds
Est. expiryDec 11, 2017(expired)· nominal 20-yr term from priority
G01N 2333/105G01N 2333/085G01N 2500/00G01N 2333/095C12Q 1/70G01N 33/56983
45
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention is broadly directed to methods of screening viral-binding compounds. In particular, the present invention provides cell-free assays to rapidly screen libraries of compounds for viral-capsid binding activity. Such compounds are useful for anti-viral treatments.
Claims
exact text as granted — not AI-modified1 . A compound represented by the molecular formulas comprising:
a) wherein
i) R 1 is
and
R 2 is selected from the group consisting of
ii) R 1 is
and
R 2 is
iii) R 1 is
and
R 2 is selected from the group consisting of
b) wherein
i) R 3 is
and
R 4 is selected from the group consisting of
ii) R 3 is
R 4 is
iii) R 3 is
R 4 is selected from the group consisting of
2 . The compound of claim 1 represented by the molecular formula:
3 . The compound of claim 1 represented by the molecular formula:
4 . The compound of claim 1 represented by the molecular formula:
5 . The compound of claim 1 represented by the molecular formula:
6 . The compound of claim 1 represented by the molecular formula:
7 . The compound of claim 1 represented by the molecular formula:
8 . The compound of claim 1 represented by the molecular formula:
9 . The compound of claim 1 represented by the molecular formula:
10 . The compound of claim 1 represented by the molecular formula:
11 . The compound of claim 1 represented by the molecular formula:
12 . The compound of claim 1 represented by the molecular formula:
13 . The compound of claim 1 represented by the molecular formula:Join the waitlist — get patent alerts
Track US2005101619A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.